We are live on ! Find out more
LOM

LTS One Management Portfolio holdings

AUM $239M
1-Year Est. Return 18.42%
This Fund
S&P 500
This Quarter Est. Return
+19.13%
1 Year Est. Return
+18.42%
3 Year Est. Return
+27.64%
5 Year Est. Return
10 Year Est. Return
AUM
$414M
AUM Growth
+$79.1M
Cap. Flow
+$24.2M
Cap. Flow %
5.84%
Top 10 Hldgs %
64.64%
Holding
27
New
5
Increased
8
Reduced
5
Closed
9

Top Buys

Rank Stock Value
1
GEHC icon
GE HealthCare
GEHC
+$23.7M
2
AMZN icon
Amazon
AMZN
+$21.1M
3
ATI icon
ATI
ATI
+$20.9M
4
CSX icon
CSX Corp
CSX
+$19.6M
5
V icon
Visa
V
+$13.9M

Top Sells

Rank Stock Value
1
WST icon
West Pharmaceutical
WST
+$24.6M
2
PRMB
Primo Brands
PRMB
+$16.3M
3
BKNG icon
Booking.com
BKNG
+$12M
4
SHW icon
Sherwin-Williams
SHW
+$10.8M
5
PCOR icon
Procore
PCOR
+$8.91M

Sector Composition

Rank Sector Weight
1 Financials 33.61%
2 Technology 28.7%
3 Consumer Discretionary 13.92%
4 Healthcare 12.29%
5 Industrials 11.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PRMB
26
Primo Brands
PRMB
$8.24B
-460,000
Closed -$16.3M

Similar funds

LTS One Management's Q2 2025 Portfolio in Review

As of Q2 2025, LTS One Management held 27 positions worth $414M, up 24% from $335M the previous quarter. Its ten largest holdings account for 65% of the portfolio.

LTS One Management deployed $24.2M of net new capital in Q2 2025, opening 5 new positions and adding to 8 existing holdings. Its largest new stake was GE HealthCare: 340,000 shares worth $25.2M.

By sector, the portfolio is most concentrated in Financials at 34% of assets, up from 27% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Coupang, an estimated $8.58M trimmed.

  • LTS One Management's largest Q2 2025 buy was GE HealthCare: 340,000 shares worth $25.2M.
  • LTS One Management added most to Aon in Q2 2025, an estimated $11M increase.
  • LTS One Management's biggest Q2 2025 reduction was Coupang, cutting an estimated $8.58M.
  • LTS One Management fully exited West Pharmaceutical in Q2 2025, selling an estimated $24.6M.
  • LTS One Management's ten largest holdings make up 65% of its $414M portfolio in Q2 2025.
  • LTS One Management opened 5 new positions and closed 9 in Q2 2025.
  • LTS One Management's portfolio value rose 24% quarter-over-quarter to $414M.

Based on LTS One Management's 13F filing for Q2 2025, filed 14 Aug 2025.